MedPath

Clinical evaluation of the safety and effectiveness of the nanofiber undereye pad to improve surface wrinkles and dark circles under the eyes

Phase 2
Recruiting
Conditions
periorbital wrinkle, dark circle and puffiness.
Changes in skin texture
R23.4
Registration Number
IRCT20210130050179N9
Lead Sponsor
ano tarpak company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

Male or female aged 18-59 years
Signed informed consent knowingly
The presence of mild to moderate periorbital wrinkle and darkness

Exclusion Criteria

Using any eye product within 2 weeks before the intervention
Strict diet in the period of 2 weeks before the intervention
Pregnancy or lactation
Being exposed to strong sunlight during the day

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of under eye dark circle and wrinkle. Timepoint: Before intervention and 6 and 28 days after treatment. Method of measurement: Based on GIAS(Global Aesthetic Improvement Scale).
Secondary Outcome Measures
NameTimeMethod
Melanin content. Timepoint: fore intervention and 6 and 28 days after treatment. Method of measurement: Mexameter.;Infra-orbital pigmentation severity and degree of lightness. Timepoint: fore intervention and 6 and 28 days after treatment. Method of measurement: Visioface.
© Copyright 2025. All Rights Reserved by MedPath